IL6 and Alzheimer disease: Compared with the AD mice, the mRNA expression levels of IL-1β, IL-4, IL-6 and TSLP in the skin lesions of the BDMC-treated mice were decreased, while the expression levels of IFN-γ were significantly increased (Figure 5A–E).